Today's pre-market stock movers: NFLX, IBM, LMT, SI and more

Moomoo Breakfast US wrote a column · Jul 19, 2022 07:33

Gainers:

In reaction to earnings/guidance:

• $Silvergate Capital(SI.US)$ +10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.)

• $AxoGen(AXGN.US)$ +3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization),

• $Novartis AG(NVS.US)$ + 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from $2.89 billion a year earlier.)

• $Halliburton(HAL.US)$ +1.1% (the oil services company beat profit and revenue expectations, as pricing gains across all product lines supported margin expansion.)

• $Johnson & Johnson(JNJ.US)$ +0.8% (Johnson & Johnson's lowered guidance is a result of strong dollar)

• $Hasbro(HAS.US)$ +0.5% (The Pawtucket, R.I.-based toy and entertainment company reported a net profit of $142 million, or $1.02 a share, compared with a loss of $22.9 million, or 17 cents a share, in the year-ago quarter.)

Other news:

• $Apellis Pharmaceuticals(APLS.US)$ +25.1% (receives FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan)

• $Avadel Pharmaceuticals(AVDL.US)$ +9.8% (receives tentative approval of LUMRYZ)

• $Sunstone Hotel Investors Inc(SHO.US)$ +7.5% (to join S&P SmallCap 600)

• $Marathon Digital(MARA.US)$ +5.1% (APLD enters into hosting contract with MARA for 200-MW of Bitcoin mining capacity)

• $Excelerate Energy(EE.US)$ +4% (signs MOU with Bulgaria's Overgas relating to regasified LNG downstream sales)

• $Amneal Pharmaceuticals(AMRX.US)$ +3.5% (provides Opana ER litigation updates against Endo Pharmaceuticals and Impax)

• $Mandiant(MNDT.US)$ +2.1% (DOJ grants early termination of the waiting period re merger with Google)

• $AstraZeneca(AZN.US)$ +1.7% (Enhertu approvedinthe EU for patients with HER2-positive metastatic breast cancer treated with one or more prior anti-HER2-based regimens)

• $Incyte(INCY.US)$ +1.4% (FDA Approval of Opzelura cream for the treatment of vitiligo)

• $Netflix(NFLX.US)$ +1.3% (asking customers in five Latin America countriestopay a fee to use shared passwords according to Bloomberg)

• $Boeing(BA.US)$ +1% (777 partners expands 737 MAX fleet ordering up to66more fuel-efficient jets)

Losers:

In reaction to earnings/guidance:

• $Invitae(NVTA.US)$ -12% (provides guidance, realigns operations, names new CEO),

• $Signature Bank(SBNY.US)$ -8.3% (Signature Bank reported Q2 earnings Tuesday of $5.26 per diluted share, up from $3.57 a year earlier.)

• $IBM Corp(IBM.US)$ -6.3% (the company reported better-than-expected results, but said its full-year free cash flow would be lower than thought and concerns over guidance weighed doubt on investors' minds.)

• $Lockheed Martin(LMT.US)$ -4.5% (the aerospace and defense contractor reported second-quarter results that missed analysts' profit and sales estimates)

• $Ally Financial(ALLY.US)$ -4.4% (the financial-services company posted net income of $454 million, down from $900 million a year earlier. Earnings were $1.40 a share, compared with $2.41 a share.

)

Other news:

• $Clene(CLNN.US)$ -5.2% (receives positive EMA opinion on Orphan Drug Designation for CNM-Au8)

• $Ultragenyx Pharmaceutical(RARE.US)$ -3.3% (provides update on GTX-102, including interim data from Phase 1/2 study)

• $Viking Therapeutics(VKTX.US)$ -1.1% (FDA has lifted clinical hold on Phase lb trial of VK0214 in patients with X-ALD)

Analyst comments:

• $Fastly(FSLY.US)$ -4.9% (downgraded to Underperform from Sector Perform at RBC Capital Mkts)

• $Asana(ASAN.US)$ -4.7% (downgraded to Underperform from Sector Perform at RBC Capital Mkts)

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

636K Views

Comment

Moomoo Breakfast US

Moomoo News Official Account

Explore and integrate top feeds before the bell

57KFollowers

13Following

56KVisitors